Perioperative measures in very long chain acyl-CoA dehydrogenase deficiency

Mol Genet Metab. 2011 May;103(1):96-7. doi: 10.1016/j.ymgme.2011.01.010. Epub 2011 Jan 27.

Abstract

Surgical procedures in patients with metabolic disorders require specific anesthetic measures based on the nature of the involved metabolic disorder. Illustrated by the history of two patients, the need for a specific perioperative regimen in patients with very long chain acyl-CoA dehydrogenase deficiency (VLCADD) is discussed. One patient deteriorated, the other patient did well without any specific measurements. Although perioperative metabolic decompensation can currently not be predicted, it is a severe complication which should be avoided. We therefore advise to consider certain perioperative precautions in all VLCADD patients: 1) age and weight adapted glucose infusion, 2) stress avoiding premedication, 3) avoidance of volatile anesthetics, 4) avoidance of long chain fatty acid containing anesthetics and 5) perioperative glucose and CK monitoring.

Publication types

  • Case Reports

MeSH terms

  • Acyl-CoA Dehydrogenase, Long-Chain / deficiency
  • Acyl-CoA Dehydrogenase, Long-Chain / genetics
  • Congenital Bone Marrow Failure Syndromes
  • Female
  • Fibroblasts / enzymology
  • Homozygote
  • Humans
  • Infant
  • Infant, Newborn
  • Lipid Metabolism, Inborn Errors*
  • Lymphocytes / enzymology
  • Male
  • Metabolism, Inborn Errors / diagnosis
  • Metabolism, Inborn Errors / genetics
  • Metabolism, Inborn Errors / therapy
  • Mitochondrial Diseases* / diagnosis
  • Mitochondrial Diseases* / genetics
  • Mitochondrial Diseases* / therapy
  • Muscular Diseases* / diagnosis
  • Muscular Diseases* / genetics
  • Muscular Diseases* / therapy
  • Mutation / genetics
  • Perioperative Period*
  • Treatment Outcome

Substances

  • Acyl-CoA Dehydrogenase, Long-Chain

Supplementary concepts

  • VLCAD deficiency